While business interruption claims are not new, recent events mean… Read more »
How to Navigate Business Interruption Claims Resulting from a Natural Disaster
Service: Advisory and Business Consulting
Navigating Safe Harbors in the Stormy Seas of Healthcare Regulations
A Comprehensive Survey of Key Regulations Impacting Arrangements Between Nonprofit… Read more »
At the 1-Yard Line? Tips for Pushing Your Deal Across the Goal Line
At the end of a deal, push forward to get the last few details ironed out before a purchase agreement gets signed.
Outsourcing of emergency departments getting more complicated
Hospitals have opted to outsource different aspects of operations, whether… Read more »
Building Confidence in Healthcare M&A: 10 Essential Questions to Ask
Navigating the complex landscape of healthcare mergers and acquisitions requires… Read more »
Updating Your Business’ Data Warehouse
Businesses are inundated with data today in all areas, from… Read more »
Three Financial Factors to Consider Before Selling Your Business
If you are a business owner, you have likely spent countless hours… Read more »
What Does it Mean to Be Data-Rich, Yet Insight-Poor?
In today’s digital economy, there is no way to measure… Read more »
The False Claims Act: The Sheriff is Back in Town
As regulations and requirements for transparent interactions between pharmaceutical, medical device and biotechnology companies (collectively “life sciences organizations” or “LSOs”), and healthcare professionals (“HCPs”) continue to evolve, certain patterns are emerging. It is becoming increasingly important to protect prescribers and companies by ensuring that transactions are commercially reasonable and FMV compliant.
Kicking the tires: Why pre-LOI due diligence is so important
LBMC shares about the importance of Pre-LOI due diligence during the M&A process.
